Short Interest in Mangoceuticals, Inc. (NASDAQ:MGRX) Rises By 237.3%

Mangoceuticals, Inc. (NASDAQ:MGRX) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 244,900 shares, a growth of 237.3% from the March 15th total of 72,600 shares. Currently, 7.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 157,300 shares, the short-interest ratio is currently 1.6 days.

Mangoceuticals Stock Performance

Shares of NASDAQ:MGRX opened at $1.82 on Tuesday. Mangoceuticals has a 52-week low of $1.49 and a 52-week high of $16.80. The company has a market capitalization of $9.41 million, a PE ratio of -0.31 and a beta of 2.41. The company has a fifty day moving average of $3.56 and a 200-day moving average of $7.29.

Mangoceuticals (NASDAQ:MGRX) last posted its earnings results on Thursday, March 20th. The company reported ($1.01) EPS for the quarter. The firm had revenue of $0.11 million during the quarter. Mangoceuticals had a negative net margin of 1,237.00% and a negative return on equity of 138.00%.

Mangoceuticals Company Profile

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.